Examples of 'b-cyclodextrin' in a sentence
Meaning of "b-cyclodextrin"
b-cyclodextrin (noun) - A type of cyclic oligosaccharide composed of sugar molecules bound in a ring structure. β-cyclodextrin is often used in chemistry and pharmaceuticals for encapsulating other molecules
How to use "b-cyclodextrin" in a sentence
Basic
Advanced
b-cyclodextrin
B-cyclodextrin was found to be effective in the recirculation process as well.
A white precipitate of B-cyclodextrin ester forms immediately.
B-cyclodextrin is preferred among the hydrophilic oligomer polymers.
The product is a complex of milbemycin and B-cyclodextrin.
B-cyclodextrin sulfobutyl ether is a particularly preferred solubility enhancing agent.
Quantitative determination of nimesulide complezed by B-cyclodextrin.
The B-cyclodextrin sulfate salt may be a sodium salt.
Recently, an amorphous cyclodextrin composition was obtained by hydroxypropylation of B-cyclodextrin.
Unreacted B-cyclodextrin was removed by elution with distilled water.
In other embodiments, the modified cyclodextrin is B-cyclodextrin sulfobutylether.
A solution of B-cyclodextrin is preferably added.
A desired derivatized cyclodextrin is ethylhydroxy B-cyclodextrin.
B-Cyclodextrin is preferable as a cyclodextrin for combination with the prostacyclins.
Pharmaceutically acceptable vehicles do not include B-cyclodextrin formulations.
B-Cyclodextrin materials comprise seven glucose moieties forming the cyclodextrin ring.
See also
The cyclodextrin may be a substituted B-cyclodextrin.
A solution of B-cyclodextrin which may be used again for separating a mixture of fatty acids.
This example describes the preparation of a derivatized B-cyclodextrin.
Several authors have described the use of B-cyclodextrin in combination with metronidazole.
The present invention is preferred for use with B-cyclodextrin.
By introducing molecules of B-cyclodextrin and by varying the concentration, the mesoporosity becomes controllable.
The ethinyl estradiol solution is added to the B-cyclodextrin solution.
As the mixture cools opened B-cyclodextrin rings re-form around the flavour molecules.
This is clearly different from a formulation of alphaxalone in hydroxypropyl B-cyclodextrin.
Another desirable cyclodextrin is any B-cyclodextrin that is water soluble.
Another particularly interesting cyclodextrin derivative is randomly methylated B-cyclodextrin.
Further, pimaricin that is in complex of with B-cyclodextrin is not measurably protected from degradation.
A preferable example of cyclodextrin is B-cyclodextrin.
B-Cyclodextrin remains in the aqueous phase and may be recovered in a solid form after cooling.
In other embodiments, the molecular includant is an ethyl hydroxy B-cyclodextrin.
In a particular embodiment, the host molecule is a B-cyclodextrin functionalized with multiple methacrylate groups.
In some embodiments, the naturally occurring volatile is encapsulated in a B-cyclodextrin.
The aryliminealkenes can be covalently attached to the B-cyclodextrin vía any suitable functional group.
A polymer according to any preceding claim, wherein the cyclodextrin is a B-cyclodextrin.
The solubility enhancement achieved by methylated B-cyclodextrin proved the existence of inclusion complex in solution.
In addition, the benzonase can be used optionally in the presence of B-cyclodextrin.
This curve clearly indicates that the sulphonated B-cyclodextrin gives the polypyrrole film conductive properties.
Captisol does not exhibit the nephrotoxicity associated with underivitized B-cyclodextrin.
Hydroxypropyl B-cyclodextrin is dissolved in water.
The present invention relates to a polysulfate of a lipophilic group-modified B-cyclodextrin.
Typically B-cyclodextrin and B-cyclodextrin derivatives are utilized in the manufacture of medicaments.
Therefore, the loading level of flavourant in unit amount of B-cyclodextrin is limited.
B-cyclodextrin salts such as beta-cyclodextrin tetradecasulfate are preferred.
DSC analysis makes it possible to conclude as to the complexing of piroxicam with B-cyclodextrin.
A combination of Sulfobutylether B-Cyclodextrin and Hypromellose.
This invention relates to a new pharmaceutical formulation of voriconazole with a sulphobutylether B-cyclodextrin.
B-cyclodextrin is particularly preferred.
Unlike molecular solvents, addition of EAN to water involves a decrease of b-cyclodextrin solubility.
Thereafter, no more unreacted B-cyclodextrin is detectable by chromatography.
The hosting moiety is preferably a cyclodextrin, more preferably a derivative of B-cyclodextrin aldehyde.
